STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic...

Full description

Bibliographic Details
Main Authors: Linlin Zhang, Ping Xiao, Fanlu Meng, Diansheng Zhong
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Current Oncology
Subjects:
STRN-ALK fusion
lung adenocarcinoma
brain metastasis
ensartinib
Online Access:https://www.mdpi.com/1718-7729/29/10/530

Internet

https://www.mdpi.com/1718-7729/29/10/530

Similar Items